Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Is There a Difference in Cannabis Effectiveness Between CRPS Type I and Type II? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

CRPS is split into two types: Type I, which occurs without a confirmed nerve injury, and Type II, which follows a diagnosed nerve injury. While both forms can cause severe pain and similar symptoms, the underlying causes differ slightly, raising the question: does this affect how well cannabis works as a CRPS alternative treatment? 

Currently, clinical research doesn’t make a clear distinction in cannabis effectiveness between the two types. However, patient case reports and early clinical evidence suggest that cannabinoids may offer relief in both cases by targeting shared symptoms like neuropathic pain, inflammation, and muscle tension. 

Book Consultation for Medical Cannabis

Comparing Treatment Response in CRPS Types 

Here’s what we know about using cannabis across both CRPS subtypes: 

  • Shared symptom relief 
    Whether or not a nerve injury is present, patients with both types often experience reduced pain, better sleep, and improved mood with cannabis use. 
    This supports its use as a broad CRPS alternative treatment, regardless of classification. 
  • No established medical separation 
    Most treatment guidance, including those involving cannabis, do not distinguish between Type I and Type II. 
    In clinical settings, decisions tend to focus more on symptom severity and patient outcomes than on subtype labels. 
  • Barriers to legal use 
    Access to medical cannabis in the UK remains limited to specialist approval, and legal use is generally guided by the presence of chronic, treatment-resistant symptoms common to both CRPS types. 

Overall, cannabis appears to be a flexible CRPS alternative treatment for both Type I and II, offering hope to patients whose symptoms have resisted standard care. 

Visit providers like LeafEase for individualised support and expert advice on cannabis therapy for CRPS. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories